Within3, the leading provider of digital collaboration solutions for the pharmaceutical and life sciences industries, today announced it has secured a new round of equity financing, led by NY venture fund, Easton Capital. This round brings Within3's aggregate funding to $20 million and continues Within3's expansion of its customer base and supporting infrastructure.

"We are changing how the healthcare industry collaborates with their thought leaders," said Lance Hill , CEO, Within3. "The funding comes at a time when we are gaining significant momentum in the marketplace. Our client base includes ten of the Top 20 pharmaceutical companies, mid-tier pharmaceutical companies, medical associations and hospitals, as well as large and boutique medical communications companies."

John H. Friedman , Managing Partner, Easton Capital Investment Group, stated, "As a first-to-market company, we are impressed by Within3's vision of solving critical business challenges through digital collaboration tools. We are pleased to assist Within3 with the capital they need to help fill this need in the marketplace."

About Within3

Within3 is the leading provider of digital collaboration solutions for the health and life sciences markets. By utilizing Within3's innovative technology, clients can efficiently convene and engage with groups of health professionals from around the world. Strong support for privacy, regulatory, and security standards underpin every implementation. By collaborating more effectively, lower costs and better health outcomes are achieved. For more information, visit www.within3.com or call 855-WITHIN3.

Contact:
Ellynn Szoke
Chief Marketing Officer
ESzoke@Within3.com